Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers (original) (raw)
BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy
Patrizia Di Fulvio
Human Mutation, 2003
View PDFchevron_right
Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women
Tusneem Elhassan
BMC Cancer, 2022
View PDFchevron_right
Genetic heterogeneity of ovarian cancer survival effects in BRCA1/2 germline mutations: a large, multi-center study
Ava Kwong
… for Cancer Research, 2011
View PDFchevron_right
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
Theodore Anagnostopoulos
Breast Cancer Research and Treatment, 2007
View PDFchevron_right
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed
Christina Tsionou
Cancer Letters, 2002
View PDFchevron_right
High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area
L. Petruzelka
Breast Cancer Research, 2005
View PDFchevron_right
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
J. Gronwald
The American Journal of Human Genetics, 2003
View PDFchevron_right
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Edu Velasco
Breast cancer research …, 2010
View PDFchevron_right
Ovarian cancer arising from the proximal fallopian tube in a patient with a BRCA2 mutation
Nina Schatz-Siemers
Gynecologic Oncology Reports
View PDFchevron_right
Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review
byung su kwon
Cancer Research and Treatment
View PDFchevron_right
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Mary Beattie
Cancer Epidemiology Biomarkers & Prevention, 2012
View PDFchevron_right
Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
luis amendola
Brazilian Journal of Medical and Biological Research, 2009
View PDFchevron_right
BRCA1 germline mutations may be associated with reduced ovarian reserve
Yalda Afshar
Fertility and Sterility, 2014
View PDFchevron_right
Case report of a rare variant of BRCA2 germline mutation in an ovarian cancer patient
Vaishnavi Kunteepuram
Indian Journal of Gynecologic Oncology, 2020
View PDFchevron_right
Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma
Patricia Hartge
PLoS ONE, 2009
View PDFchevron_right
BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
Nahed Baddour
Gynecologic Oncology Reports, 2020
View PDFchevron_right
Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland
Janusz Limon
Human Mutation, 2000
View PDFchevron_right
Modern Approaches and Future Perspectives on Breast and Ovarian Cancer Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers: A Literature Overview
Sandra Sarnacka
Journal of Education, Health and Sport, 2024
View PDFchevron_right
The use of cytogenetics in understanding ovarian cancer
Jeremy A . Squire
Biomedicine & Pharmacotherapy, 2004
View PDFchevron_right
DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas
Salud Borrego
2013
View PDFchevron_right
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
diana torres
Journal of the National Cancer Institute, 2016
View PDFchevron_right
Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland
Magdalena Pasinska
Clinical Genetics, 2003
View PDFchevron_right
Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases
Sandrine M Caputo
Nucleic Acids Research, 2011
View PDFchevron_right
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Mary Beattie
Cancer Epidemiology Biomarkers & Prevention, 2012
View PDFchevron_right
High-grade serous ovarian carcinoma and detection of inactivated BRCA genes from biopsy material of Slovak patients
Zora Lasabova
Neoplasma, 2021
View PDFchevron_right
A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history
Maria Maddalena Galante
Familial Cancer, 2010
View PDFchevron_right
Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients
Rumyana Dodova
BMC Cancer, 2015
View PDFchevron_right
Integrated genomic analyses of ovarian carcinoma
William Chang
Nature, 2011
View PDFchevron_right
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease
Ludwine Messiaen
Human Mutation, 1999
View PDFchevron_right
Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients
Cibele Bonvicino
Breast Cancer Research and Treatment, 2020
View PDFchevron_right
Integrated analysis of germline and somatic variants in ovarian cancer
Elaine Mardis
Nature Communications, 2014
View PDFchevron_right
Predisposition testing for breast and ovarian cancer susceptibility
Kathleen Calzone
Seminars in Oncology Nursing, 1997
View PDFchevron_right
BRCA1 and BRCA2mutations in breast cancer patients from Venezuela
Nigmet Consigliere
Biological Research, 2012
View PDFchevron_right
Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer
Zuhal Altıntaş
Polish Journal of Pathology, 2024
View PDFchevron_right
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
Jean-louis Mandel
European Journal of Cancer
View PDFchevron_right